A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)
Conditions: Vasovagal Syncope (VVS); Syncope Interventions: Drug: Ondansetron; Drug: Placebo Sponsor: University of Calgary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials